ANDA Submission Lull Is Now A Trend, As Are Sluggish Approval Numbers
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has not received more than 49 ANDAs in a single month since the June 2014 rush.
You may also be interested in...
Another ANDA Submission Surge Begins
US FDA receives more than 100 ANDAs during the first month of GDUFA year five, suggesting sponsors want the new 10-month review goal and cheaper user fee.
Another ANDA Submission Surge Begins
US FDA receives more than 100 ANDAs during the first month of GDUFA year five, suggesting sponsors want the new 10-month review goal and cheaper user fee.
ANDA Approvals, Submissions Decline With New Review Goal Coming
Is a rush of generic applications seeking the 10-month clock on the way?